Peter Recknadel

Dr. Peter Recknagel has spent nearly 20 years at the intersection of critical care and MedTech evidence, rooted in early research in hemodynamic monitoring and the molecular mechanisms of organ failure in sepsis at University Hospital Jena and UCL. As a MedTech Evidence Strategist, he now builds evidence strategies, from study design to clinical communication, across cardiovascular disease, extracorporeal organ support and immunomodulation therapies.